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Cancer immuno-gene therapy is an introduction of nucleic acids encoding immunostimulatory proteins,
such as cytokine interleukin 12 (IL-12), into somatic cells to stimulate an immune response against
a tumor. Various methods can be used for the introduction of nucleic acids into cells; magnetofection
involves binding of nucleic acids to magnetic nanoparticles with subsequent exposure to an external
magnetic ﬁeld. Here we show that surface modiﬁed superparamagnetic iron oxide nanoparticles
(SPIONs) with a combination of polyacrylic acid (PAA) and polyethylenimine (PEI) (SPIONs-PAA-PEI)
proved to be safe and effective for magnetofection of cells and tumors in mice. Magnetofection of cells
with plasmid DNA encoding reporter gene using SPIONs-PAA-PEI was superior in transfection efﬁciency
to commercially available SPIONs. Magnetofection of murine mammary adenocarcinoma with plasmid
DNA encoding IL-12 using SPIONs-PAA-PEI resulted in signiﬁcant antitumor effect and could be further
reﬁned for cancer immuno-gene therapy.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
The translation of nanotechnology has already widespread into
biomedicine for diagnostic, therapeutic and theranostic purposes
[1]. Superparamagnetic iron oxide nanoparticles (SPIONs) can be
guided by an external magnetic ﬁeld, yet due to quantum effects at
the nanometer scale they do not retain residual magnetism in the
absence of an external magnetic ﬁeld [2], which makes them
especially suitable for diverse biomedical applications [3]. In the
ﬁeld of oncology, SPIONs have been exploited for diagnostic
purposes as contrast enhancers for magnetic resonance imaging
and as vehicles for biomarkers detection [4]. For therapeutic
purposes SPIONs have been used for isolation and transfection of
hematopoietic stem cells for gene therapy emagselectofection [5],-NC-ND license.in magnetic hyperthermia [6] and as delivery systems for different
therapeutics [7].
Magnetofection is a non-viral transfection method that uses an
external magnetic ﬁeld to target cells with nucleic acids that are
bound to magnetic nanoparticles [8]. Magnetofection has recently
celebrated its 10th anniversary, and its progress and prospects are
described in the thorough review paper [9]. Many studies regarding
magnetofection have used commercially available SPIONs
[8,10e18]. The majority were coated and/or functionalized with
positively charged PEI due to its electrostatic interaction with
negatively charged sugar phosphate backbone of nucleic acid and
proton sponge effect, which enables release of SPIONs-PEI-nucleic
acid complexes from endolysosomes into cytoplasm. Although PEI
is a transfection agent per se [19], it has been shown that when
coupled with SPIONs, magnetofection efﬁciency increased in
comparison to the transfection efﬁcacy of PEI only [11,20]. Despite
of its extended usage for gene delivery, PEI compromises cell
membrane integrity and induces formation of channels in the outer
mitochondrial membrane [21], which could lead to cell death.
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cytotoxic polyacrylic acid (PAA), have been considered as endo-
somolytic polymers [22]. It has been shown that the inclusion of
PAA to PEI-DNA transfection complexes not only increased reporter
gene expression but also reduced toxicity in vivo [23]. However,
there are no reports about SPIONs coated with anionic PAA and
functionalizedwith cationic PEI for magnetofection of plasmid DNA
encoding either reporter or therapeutic genes. Thus far magneto-
fection of tumors using SPIONs for magnetically-guided immuno-
gene therapy has not resulted in signiﬁcant antitumor effect [14,16].
In terms of preparing effective magnetically-guided delivery
system for immuno-gene therapy of tumors, wemodiﬁed surface of
SPIONs with a double layer of PAA and PEI endosomolytic polymers
(SPIONs-PAA-PEI). After evaluating physicochemical properties and
binding plasmid DNA encoding either reporter gene for enhanced
green ﬂuorescent protein (GFP) (pDNAGFP) or therapeutic gene for
murine interleukin 12 (IL-12) (pDNAIL12) to SPIONs-PAA-PEI, we
tested cytotoxicity of so prepared SPIONs-PAA-PEI-pDNAGFP. We
implemented magnetofection of cells of different cell lines with
pDNAGFP or pDNAIL12 using SPIONs-PAA-PEI, and we compared its
efﬁcacy to transfection efﬁcacy using commercially available
magnetic nanoparticles and two well-established non-viral trans-
fection methods, electroporation and lipofection. In vivo, we
determined acute toxicity and biodistribution of SPIONs-PAA and
SPIONs-PAA-PEI-pDNAGFP, and tested non-invasive magnetofection
ofmurinemelanoma andmammary adenocarcinomawith pDNAGFP
using SPIONs-PAA-PEI. For the proof-of-principle, we determined
antitumor effectiveness after magnetofection of murine mammary
adenocarcinoma tumors with pDNAIL12 using SPIONs-PAA-PEI.2. Materials and methods
2.1. De novo synthesis of SPIONs-PAA-PEI
SPIONs were synthesized by alkaline co-precipitation of ferrous and ferric
sulfates, (FeSO4  7H2O, 98% and (Fe2(SO4)3  xH2O)) (Alfa Aesar, Ward Hill, MA), in
an aqueous solution according to the Massart method [24]. Brieﬂy, 250 ml of 0.5 M
aqueous solution containing ferric and ferrous ions in a weight-to-weight (w/w)
ratio of 1.5:1 were precipitated with 150 ml of 25% ammonium hydroxide solution
(NH4OH) (Sigma-Aldrich, St. Louis, MO) under magnetic stirring at 600 rpm for
30 min at room temperature. After SPIONs were obtained, alkaline medium was
removed and replaced with distilled water subsequent to magnetic decantation of
SPIONs (repeated 3 times) in order to obtain a magnetic liquid, i.e. ferroﬂuid (FF).
SPIONs were coated in situ with 45% (w/w) water solution of poly(acrilyc acid,
sodium salt) (PAA) with molecular weight of 8 kDa (Sigma-Aldrich) by mixing
100 ml of FF-SPIONs and 100 ml of PAAwater solution of equal mass concentrations
at 10 mg/ml under magnetic stirring at 400 rpm for 5 min at room temperature.
Thereafter FF-SPIONs-PAA was sterilized by ﬁltration using 0.22 mm pore size
syringe ﬁlter (Techno Plastic Products e TPP, Trasadingen, Switzerland). For the
evaluation of physicochemical properties and for the experiments stock solution of
the FF-SPIONs-PAA was diluted with distilled water to a working concentration of
1 mg/ml. Functionalization of SPIONs-PAA was performed directly prior to the
experiments with branched cationic polymer polyethylenimine (PEI) with molec-
ular weight of 25 kDa (Sigma-Aldrich). For in vitro experiments, FF-SPIONs-PAA at
1 mg/ml was added into 0.1 mg/ml PEI water solution at mass ratios 0.5:1, 0.6:1,
0.7:1, 0.8:1 and 0.9:1. For in vivo experiments, FF-SPIONs-PAA at 1 mg/ml was added
into 1 mg/ml PEI water solution at the mass ratio 0.6:1.
2.1.1. Binding plasmid DNA to SPIONs-PAA-PEI
Two plasmid DNA (pDNA) were used for binding to SPIONs-PAA-PEI: pDNA
containing reporter gene encoding GFP (pDNAGFP) under the control of the consti-
tutive cytomegalovirus (CMV) promoter (pCMV-EGFP-N1; Clontech, Mountain View,
CA) or pDNA containing therapeutic gene encoding murine IL-12 (pDNAIL12) under
the control of hybrid promoter EF-1a/HTLV, consisting of elongation factor 1a and 50
untranslated region of the human T-cell leukemia virus, with open reading frame
(ORF) (pORF-mIL-12; InvivoGen, San Diego, CA). Ampliﬁcation of pDNAGFP and
pDNAIL12 was performed in competent Escherichia coli cells (TOP10; Life Technol-
ogies, Carlsbad, CA), isolation using Qiagen Maxi-Endo-Free Kit (Qiagen, Hilden,
Germany) and subjection to quality control and quantity determination using
agarose gel electrophoresis and spectrophotometer (NanoDrop 2000; Thermo
Scientiﬁc, Wilmington, DE). Dilution of pDNAGFP and pDNAIL12, exhibiting the ratio
between the absorbance at 260 nm and 280 nmwavelengths (A260/A280) more than1.8, was made with endotoxin-free water to a working concentration of 1 mg/ml.
SPIONs-PAA, PEI and pDNAGFP or pDNAIL12 were prepared at the mass ratio 0.6:1:1
(SPIONs-PAA-PEI-pDNAGFP or SPIONs-PAA-PEI-pDNAIL12). The ability of SPIONs-
PAA-PEI complexes to bind both pDNA was determined by 45 min electrophoresis
at 100 V on a 1% (w/v) agarose gel stained with 0.5 mg/ml ethidium bromide.
Visualization of the bands was performed under ultraviolet transilluminiscence
(GelDoc-It TS 310; Ultra-Violet Products (UVP), Upland, CA). DNA ladderMassRuler
DNA Ladders, ready-to-use (Thermo Fisher Scientiﬁc, Waltham, MA) was utilized.
2.1.2. Physicochemical properties of SPIONs, SPIONs-PAA, SPIONs-PAA-PEI and
SPIONs-PAA-PEI-pDNAGFP
Chemical composition and crystallographic structure of SPIONs and SPIONs-PAA
were determined by X-ray diffractometry (XRD) measuring within the range of
a diffraction angle 2Q from 25 to 80 (AXS, D5005; Bruker, Billerica, MA). The mean
crystallite size was calculated according to the broadening of the (311) characteristic
peak of the XRD pattern using the Scherrer equation [25]. Size and shape of SPIONs
and SPIONs-PAA were evaluated by transmission electron microscopy (TEM) (2000
FX with EDS AN10000; JEOL, Tokyo, Japan). The estimated size from TEM was
obtained by measuring diameters of ten SPIONs and SPIONs-PAA from representa-
tive samples. Also, morphology of SPIONs-PAA-PEI and SPIONs-PAA-PEI-pDNAGFP
was visualized by TEM.
Magnetic characterization of SPIONs and SPIONs-PAA was conducted using
a magnetometer (Quantum Design MPMS XL-5 SQUID, San Diego, CA) equipped
with a 50 kOemagnet, operating in the temperature range 2e400 K. In the ﬁrst set of
measurements, the magnetization vs. the magnetic ﬁeld curves, M(H), and the
magnetic susceptibility, c(T), of dry SPIONs and SPIONs-PAA were determined at
T ¼ 300 K. In the second set of measurements, the magnetization vs. the magnetic
ﬁeld curves, M(H), and the magnetic susceptibility, c(T), of FF-SPIONs and FF-
SPIONs-PAA were determined at T ¼ 300 K.
The zeta (z) potentials of FF-SPIONs at pH ¼ 9.5, FF-SPIONs-PAA at pH ¼ 8.5 and
FF-SPIONs-PAA-PEI at pH ¼ 8 were determined by zetameter measuring electro-
phoretic mobility at 21 C applied to the Henry equation (Zetasizer Nano ZS; Mal-
vern Instruments, Malvern, UK).
2.2. Cell lines
Experiments were performed in two malignant melanoma cell lines, mouse
B16F1 (LGC Standards, Teddington, UK) and human SK-MEL-28 (American Type
Culture Collection (ATCC), Manassas, VA), and two normal cell lines, human meso-
thelial MeT-5A (ATCC) and mouse ﬁbroblasts L929 (LGC Standards). B16F1, SK-MEL-
28 and L929 cells were maintained in advanced minimum essential medium (MEM)
(Life Technologies) whereas MeT-5A cells were maintained in advanced Roswell
Park Memorial Institute (RPMI) 1640 medium (Life Technologies). Both media were
supplemented with 5% fetal bovine serum (FBS; Life Technologies), 10 ml/l L-gluta-
mine (Life Technologies), 100 U/ml penicillin (Grünenthal, Aachen, DE) and 50 mg/ml
gentamicin (Krka, Novo mesto, Slovenia). Cells were grown in Petri dishes of 15 cm
diameter (TPP) and incubated in a humidiﬁed atmosphere of 5% CO2 at 37 C until
they reached at least 90% conﬂuence. Then the medium was removed, cells were
washed with phosphate-buffered saline (PBS) and detached with 0.25% trypsin/
EDTA in Hank’s buffer (Life Technologies). An equal volume of mediumwith FBS for
trypsin inactivation was then added, cells were collected, centrifuged, counted and
used for subsequent experiments.
2.2.1. Cytotoxicity of SPIONs-PAA-PEI-pDNAGFP
Cytotoxicity of SPIONs-PAA-PEI bound to pDNAGFP (SPIONs-PAA-PEI-pDNAGFP)
was tested on cells derived from B16F1, SK-MEL-28, L929 and MeT-5A cell lines by
cell viability alamarBlue (Life Technologies) assay measuring metabolic activity of
cells. For the experiments 2.5  104 B16F1, 5  104 SK-MEL-28, 2.5  104 L929 and
7.5104 MeT-5A cells were plated in 1 ml of cell culture medium on clear-bottomed
24-well plates (TPP). Immediately thereafter SPIONs-PAA, PEI and pDNAGFP alone
were added to cells in concentrations of 1.2 mg/ml, 2 mg/ml and 2 mg/ml, respectively.
SPIONs-PAA-PEI complexes, PEI-pDNAGFP and SPIONs-PAA-PEI-pDNAGFP trans-
fection complexes were prepared at mass ratios 0.6:1, 1:1 and 0.6:1:1, respectively,
and added to cells at same concentrations as described above. Cells were either
directly incubated or exposed to Nd-Fe-B magnets with surface magnetic ﬂux
density B ¼ 403 mT and magnetic gradient G ¼ 38 T/m (i.e. an external magnetic
ﬁeld) for 15 min. After 72 h incubation, 500 ml of cell culture medium was removed
and 50 ml of alamarBlue reagent (Life Technologies) was added, followed by 2-h
incubation. The ﬂuorescence of formed resoruﬁn product was quantiﬁed using
a ﬂuorescence microplate reader (Inﬁnite F200, Tecan, Männedorf, Switzerland) at
560 nm excitation wavelength and 590 nm emission wavelength. Cell survivals of
exposed cells are presented as the percentages of the ﬂuorescence obtained from
untreated control cells.
2.2.2. Internalization of SPIONs-PAA-PEI-pDNAGFP into cells
Internalization of SPIONs-PAA-PEI bound to pDNAGFP (SPIONs-PAA-PEI-
pDNAGFP) into cells was evaluated qualitatively by TEM (CM100; Philips, Amsterdam,
the Netherlands) and quantitatively by inductively coupled plasma mass spectrom-
eter (ICP-MS) (Agilent 7700, Tokyo, Japan) determining iron (Fe) concentrations in
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pDNAGFP corresponds to the concentration of Fe in the samples, which is presented as
the amount of Fe per cell normalized to control cells. For the experiments 5  104
B16F1,1105 SK-MEL-28, 5104 L929 and 1.5105MeT-5A cellswere plated in 1ml
of cell culture medium on clear-bottomed, 24-well plates (TPP). After 24 h or 48 h of
incubation, complexes of SPIONs-PAA, PEI and pDNAGFP were prepared at the mass
ratio of 0.6:1:1, respectively, and given to cells at pDNAGFP concentration of 2 mg/ml.
Cells were exposed to an external magnetic ﬁeld for 15 min. After 4 h or 24 h of
incubation, themediumwas removed and cells werewashedwith PBS for qualitative
andquantitativedeterminationof internalization. Todetermine the internalizationof
SPIONs-PAA-PEI-pDNAGFP qualitatively, cells were ﬁxed in a mixture of 4% (w/v)
paraformaldehyde and 2.5% (v/v) glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4,
for 1 h at 4 C. Post-ﬁxation was carried out in 1% osmium tetroxide in 0.1 M caco-
dylate buffer for 2 h, followed by dehydration in graded ethanol and embedding in
Epon 812 resin. Ultrathin sections (60 nm) were cut, counterstained with uranyl
acetate and lead citrate and examined with TEM. To determine the internalization of
SPIONs-PAA-PEI-pDNAGFP quantitatively, cellswere trypsinized, counted, collected in
4.5 ml cryo tubes (BD Biosciences, Two Oak Park, Bedford, MA) and stored at18 C.
Prior to analysis, samples were equilibrated to room temperature and digested with
amixture of 0.2ml 65% nitric acid and 0.2ml 30% hydrogenperoxide by incubation at
90 C for at least 24 h to obtain clear solutions. Sampleswere then dilutedwithwater
to 10 mL for the analysis with ICP-MS.
2.2.3. Magnetofection of cells with pDNAGFP using SPIONs-PAA-PEI
To optimize the mass ratio between SPIONs-PAA, PEI and pDNAGFP for magne-
tofection of cells using SPIONs-PAA-PEI, 5  104 B16F1, 1  105 SK-MEL-28, 5  104
L929 and 1.5105 MeT-5A cells were plated in 1 ml of cell culture medium on clear-
bottomed, 24-well plates. After 24 h of incubation, transfection complexes of SPIONs-
PAA, PEI and pDNAGFPwere prepared atmass ratios from0.5:1:1 to 0.9:1:1 and added
to cells at pDNAGFP concentration of 2 mg/ml. Cells were exposed to an external
magnetic ﬁeld for 15 min. After 24-h incubation, transfection efﬁcacy was evaluated
qualitatively with ﬂuorescent microscope by recording images with digital camera
(Olympus DP50) attached to ﬂuorescent microscope (Olympus IX70, Hamburg,
Germany) at 488 nm excitation wavelength and 507 nm emission wavelength. The
differences in transfection of cells with pDNAGFP between the absence and presence
of an external magnetic ﬁeld are presented as potentiating factors. Thereafter cells
were trypsinized, collected in 15 ml conical falcon tubes (TPP) and centrifuged. The
supernatant was removed and cells were resuspended to 5 ml polystyrene round-
bottom tubes (BD Biosciences) in 1 ml of PBS for quantitative determination of
transfection efﬁcacy with ﬂow cytometer (BD FACSCanto II; Becton Dickinson, San
Jose, CA), identifying the percentage of GFP-positive (ﬂuorescent) cells and
measuring the median ﬂuorescence intensity of the GFP. Statistics between the
magnetofection efﬁcacies using SPIONs-PAA-PEI, prepared as SPIONs-PAA-PEI-
pDNAGFP, at different mass ratios were analyzed by one way ANOVA. Statistics
between the transfection efﬁcacies using SPIONs-PAA-PEI in the absence and pres-
ence of an external magnetic ﬁeld at the particular mass ratio were analyzed by
Student’s t-test.
Furthermore, comparison of the transfection efﬁcacy of B16F1 cells with
pDNAGFP was made between: SPIONs-PAA-PEI prepared as SPIONs-PAA-PEI-
pDNAGFP at themass ratio 0.6:1:1, PEI prepared as PEI-pDNAGFP at themass ratio 1:1,
3 different commercially available magnetic nanoparticles for magnetofection
(CombiMAG and PolyMag purchased at chemicell GmbH, Berlin, Germany and
MATra bought from IBA GmbH, Göttingen, Germany), electroporation, lipofection
using Lipofectamine 2000 (Life Technologies) and SPIONs-PAA-PEI in the absence
of an external magnetic ﬁeld. Cells for transfection with PEI and SPIONs-PAA-PEI in
the absence and presence of an external magnetic ﬁeld as well as for electroporation
were maintained in the medium as described above whereas cells for magneto-
fection with commercially available magnetic nanoparticles and lipofection were
maintained in MEM, supplemented with 10% FBS and 10 ml/l L-glutamin. For
transfection with PEI and SPIONs-PAA-PEI in the absence and presence of an
external magnetic ﬁeld, 5  104 cells were plated in 1 ml of cell culture medium on
clear-bottomed, 24-well plates (TPP). After 24-h incubation, 2 mg/ml of pDNAGFP was
prepared as PEI-pDNAGFP and SPIONs-PAA-PEI-pDNAGFP at mass ratio of 1:1 and
0.6:1:1, respectively, and added to cells. Cells transfected with SPIONs-PAA-PEI-
pDNAGFP were either exposed to Nd-Fe-B magnets for 15 min or not. After 24 h of
incubation, cells were prepared for analysis by ﬂow cytometer as described above.
For electroporation a dense cell suspensionwith a concentration of 1 106 cells and
10 mg of pDNAGFP in 50 ml of electroporation buffer [26] was placed between two ﬂat
parallel stainless steel electrodes with a 2 mm gap connected to the GT-1 electro-
porator (University of Ljubljana, Faculty of Electrical Engineering, Ljubljana,
Slovenia) and subjected to 8 square-wave electric pulses with an amplitude per
distance ratio 600 V/cm, 5 ms duration time, and 1 Hz repetition frequency. After
electroporation, cells were incubated for 5 min at the room temperature and then
plated to 6 cm diameter Petri dishes (TPP). After 24-h incubation, cells were
prepared for analysis by ﬂow cytometer as described above. For lipofection and
magnetofectionwith commercially availablemagnetic nanoparticles either 2.5104
or 5  104 cells were plated in 1 ml of cell culture medium on clear-bottomed, 24-
well plates (TPP). After 24-h incubation, 1.7 mg/ml of pDNAGFP was used for lip-
ofection in accordance to manufacturer’s instructions whereas for magnetofectionwith commercially available magnetic nanoparticles 4 mg/ml of pDNAGFP was
coupled to nanoparticles according to the instructions of the manufacturer and
given to cells with subsequent 15-min exposure to Nd-Fe-B magnets. After 24-h
incubation, cells were prepared for analysis by ﬂow cytometer as described above.
2.2.4. Magnetofection of cells with pDNAIL12 using SPIONs-PAA-PEI
The comparison of the transfection efﬁcacy of B16F1 cells with pDNAIL12 was
made between: magnetofection using SPIONs-PAA-PEI prepared as SPIONs-PAA-
PEI-pDNAIL12 at the mass ratio 0.6:1:1, PEI prepared as PEI-pDNAIL12 at the mass
ratio 1:1, electroporation, lipofection and SPIONs-PAA-PEI in the absence of
magnetic ﬁeld. The transfections of cells with pDNAIL12 was performed likewise the
transfection of pDNAGFP-based experiments. After either 24-h incubation, the
mediumwas transferred into 1.5 ml cryo tubes (Corning Incorporated, Corning, NY)
and centrifuged in order to eliminate cell debris. Thereafter the supernatant was
analyzed for the amount of IL-12 p70 by enzyme-linked immunosorbent assay
(ELISA) kits (R&D Systems, Minneapolis, MN) in accordance to the manufacturer’s
instructions. Transfection efﬁcacy is presented in picograms of secreted biologically
active heterodimer p70 of IL-12 per cell.
2.3. Mice
In vivo experiments were performed on female BALB/c and C57Bl/6 mice
obtained from the Institute of Pathology, Faculty of Medicine, University of Ljubljana,
Slovenia. At the beginning of the experiments mice were 10e12 weeks old and were
housed in speciﬁc pathogen free colony at constant room temperature 20e24 C,
relative humidity 55  10% and 12 h light/dark cycle. Food and water were
provided ad libitumunless otherwise stated. Animalswere subjected to an adaptation
period of 7e10 days before the experiments were carried out. All procedures were
performed in compliance with the ofﬁcial guidelines of the Ministry of Agriculture,
Forestry and Food of the Republic of Slovenia (permission no. 34401-11/2009/6).
2.3.1. In vivo acute toxicity and biodistribution of SPIONs-PAA and SPIONs-PAA-PEI-
pDNAGFP
Acute toxicity and biodistribution of SPIONs-PAA and SPIONs-PAA-PEI bound to
pDNAGFP (SPIONs-PAA-PEI-pDNAGFP) were assessed in BALB/c mice. Acute toxicity of
SPIONs-PAA was evaluated using Up-and-Down Procedure (UDP) protocol by the
Organization for Economic Co-operation and Development (OECD). Biodistribution
of SPIONs-PAA and SPIONs-PAA-PEI-pDNAGFP was determined quantitatively by
measuring iron concentration in samples of digested internal organs, i.e. lungs,
heart, spleen, liver and kidneys, using ICP-MS, and qualitatively by recording images
of histological specimens of liver with digital camera (Nikon DXM1200F; Nikon,
Tokyo, Japan) attached to light microscope (Nikon Eclipse 80i). According to the
OECD guidelines, food was restrained 3 h before and 1 h after the experiment
whereas water was provided ad libitum. For the acute toxicity determination
assessing the median lethal dose (LD50) mice were injected intraperitoneally (i.p.)
with 1ml of high doses of SPIONs-PAA (175mg/kg and 550mg/kg). The highest dose
suggested by the guidelines (2000 mg/kg) was not possible to inject due to the
restricted i.p. injection volume and limited highest concentration of SPIONs-PAA
stock solution. Additionally, body weight was monitored by weighing mice at the
commencement and throughout the experiment every 4 days after the initial
administration of SPIONs-PAA. Changes in bodyweight are presented as the ratios of
the intermediate and ﬁnal body weights to the initial body weight. Based on the
results of our in vitro experiments and regarding pDNAIL12 dosage optimization
after i.t. administration followed by electroporation of tumors [27], three mice per
group were also injected i.p. with low doses of SPIONs-PAA (1.2 mg/kg) and SPIONs-
PAA-PEI-pDNAGFP (1.2-2-2 mg/kg, respectively). Control group of animals was
injected i.p. with distilled water in the same volume as SPIONs-PAA and SPIONs-
PAA-PEI-pDNAGFP were given (1 ml). Animals were sacriﬁced 14 days after the
commencement of the experiment. Organs were removed, weighted and stored in
4 ml cryo vials (BD Biosciences) at 18 C for ICP-MS analysis. Before analysis,
microwave digestion of organs was applied, and then the measurement was per-
formed likewise the quantitative internalization of SPIONs-PAA and SPIONs-PAA-
PEI-pDNAGFP into cells. Additionally, qualitative evaluation of biodistribution of
SPIONs-PAA was made in liver, which was immediately after the excision ﬁxed in
10% (w/v) buffered formalin phosphate and embedded in parafﬁn. From parafﬁn
10 mm thick sections were cut and stained with Perl’s Prussian blue histochemical
method. The Perls histochemical reaction is adequate for the detection of iron as
ferritin and hemosiderin in higher vertebrates [28].
2.3.2. Magnetofection of tumors with pDNAGFP using SPIONs-PAA-PEI
Magnetofection of B16F1 melanoma tumors, syngeneic to C57Bl/6 mice, and TS/
A mammary adenocarcinoma tumors, syngeneic to BALB/c mice, with pDNAGFP was
evaluated in frozen tumor sections, which were examined for the GFP level and
spatial distribution by recording images with digital camera (Olympus DP72)
attached to ﬂuorescent microscope (Olympus BX51). Tumors were induced by
inoculating 1.0  106 B16F1 cells or 2.0  106 TS/A cells in 0.1 ml of 0.9% NaCl
subcutaneously into the right ﬂanks of mice. Cells of both cell lines were prepared
from in vitro cultures growing in advanced MEM. After 7e9 days, when the tumors
reached approx. 40 mm3, mice were randomly divided into 6 groups consisting of 3
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First group of animals was injected intratumorally (i.t.) with 40 ml of distilled water.
Second group of animals was injected i.t. 15 mg of pDNAGFP in 40 ml of endotoxin-free
water. Third group of animals was injected i.t. with 15 mg of pDNAGFP prepared in
40 ml of PEI-pDNAGFP complexes at the mass ratio 1:1. Fourth and ﬁfth group of
animals were injected i.t. with 15 mg of pDNAGFP prepared in 40 ml of SPIONs-PAA-
PEI-pDNAGFP complexes at the mass ratio of 0.6:1:1. Thereafter, Nd-Fe-B magnets
(same magnets as used for in vitro experiments) were placed above the tumors of
the fourth group and ﬁxed with the tape for 30 min. Sixth group of animals was
injected i.t. with 15 mg of pDNAGFP in 40 ml of endotoxin-free water. After 10 min,
electroporation of tumors was performed by applying eight square-wave electric
pulses, delivered in 2 sets of 4 pulses in perpendicular directions, at a frequency of
1 Hz, amplitude over distance ratio of 600 V/cm and 5ms duration through 2 parallel
stainless steel electrodes with a 7 mm gap connected to GT-1 electroporator. All
injections were performed using 0.3 ml insulin syringes with 28-gaugee needles
(Terumo, Tokyo, Japan) on anesthetized animals. Also, fourth group of animals was
subjected to anesthesia during the ﬁxation of Nd-Fe-B magnets above the tumors.
General anesthesia was induced and maintained by placing mice in a clear plastic
chamber while administering 1.5e3% vapor set of isoﬂuranewith oxygen ﬂow at 1 l/
min (Draeger, Lübeck, Germany). Tumors were excised 24 h after the last injection,
embedded in Tissue-Tek OCT Compound (Sakura Finetek, Torrance, CA) and stored
at 18 C. Frozen tumor sections of 20 mmwere cut every 150 mm of the tumor with
cryostat (Leica CM1850; Leica Mycrosystems, Wetzlar, Germany) for the GFP level
and spatial distribution examination.
2.3.3. Magnetofection of tumors with pDNAIL12 using SPIONs-PAA-PEI
For the proof-of-principle, transfection of TS/A tumors with pDNAIL12 was
performed in BALB/c mice. Transfection efﬁcacy of tumors was determined by
calculating tumor volumes after measuring 3 orthogonal tumor diameters (e1, e2 and
e3) with Vernier caliper, using the formula V ¼ p e1  e2  e36 . TS/A tumors were
induced likewise the tumors for the pDNAGFP-based experiments. After 7e9 days,
when the tumors reached approx. 40 mm3, mice were randomly divided into 9
groups consisting of 4 or 5 animals and subjected to different experimental protocols
for 3 days consecutively. The protocol for the ﬁrst six groups was the same as for the
pDNAGFP-based experiments. Seventh groupof animalswas subjected only to electric
pulses, whichwere delivered in the samewayas for the pDNAGFP-based experiments.
Eighth group of animals was injected i.t. 15 mg of PEI in 40 ml of endotoxin-freewater.
Ninth group of animals was injected i.t. 9 mg of SPIONs-PAA in 40 ml of endotoxin-free
water with subsequent exposure to Nd-Fe-B magnets for 30 min that were placed
above the tumors with the tape. Tumor growth and regression was monitored until
the tumors reached between 300 and 350 mm3; then the animals were euthanized.
Tumor growth delay was calculated when the mean value of the tumor volume of all
experimental groups reached 200 mm3 because the tumors of SPIONs-PAA-PEI-
pDNAIL12-treated mice and after pDNAIL12 electrotransfer started to delay in
growth after they had already reached doubling or tripling volume.
2.4. Statistical analysis
All quantitative data were tested for normality of distribution by Shapiro-Wilk
test and are presented as means  standard errors (s.e.m.). Student’s t-test was
used to evaluate the differences in the transfection efﬁcacy between the absence and
presence of magnetic ﬁeld regarding optimization of magnetofection of cells with
pDNAGFP using SPIONs-PAA-PEI. All other quantitative datawere analyzed by oneway
ANOVA, and tested for signiﬁcance by Holm-Sidak test. Alpha level was set to 0.05.
When P values were 0.05 or less, differences were considered statistically signiﬁcant.
All statistical analyses were performed by SigmaPlot 11 (Systat Software, San Jose, CA).
3. Results
3.1. De novo synthesis of SPIONs-PAA-PEI
We synthesized SPIONs for magnetofection by alkaline co-
precipitation of ferrous and ferric ions in aqueous solution
according to the Massart method [24]. To increase magnetofection
efﬁcacy and reduce PEI-related cytotoxicity, we coated SPIONs in
situ with pH-responsive anionic polymer PAA and functionalized
obtained SPIONs-PAA with cationic polymer PEI through electro-
static interaction between highly negative surface of SPIONs-PAA
and positively charged polycation PEI. Functionalization of
SPIONs-PAA with PEI was performed directly prior to the pDNAs
binding due to incipient stability of the ferroﬂuid containing
SPIONs-PAA-PEI. All results regarding physicochemical properties
of SPIONs, SPIONs-PAA and SPIONs-PAA-PEI stand for a represen-
tative sample.3.1.1. Physicochemical properties of SPIONs, SPIONs-PAA, SPIONs-
PAA-PEI and SPIONs-PAA-PEI-pDNAGFP
From the TEM images (Fig. 1a), diameter of spherical SPIONs was
estimated to be 8  1 nm whereas estimated diameter of SPIONs-
PAAwas 10  1 nm. After functionalization of SPIONs-PAAwith PEI
(SPIONs-PAA-PEI), less than 2 nm-thick amorphous edge around the
crystalline SPIONs-PAA was observed. After binding pDNAGFP to
SPIONs-PAA-PEI, a bubble-like-formation around clusters of SPIONs-
PAA-PEI was noted. Crystallographic structure of SPIONs and
SPIONs-PAA was iron oxide maghemite (g-Fe2O3) as observed from
theXRDpatterns (Fig.1b). Immobilizationof pDNAGFP andpDNAIL12
was observed after binding to SPIONs-PAA-PEI andPEI byagarose gel
electrophoresis (Fig. 1c). Contrariwise, highly negative surface of
SPIONs-PAA without PEI functionalization remained unattached to
electronegative oxygens of phosphate groups of pDNA.
The ferrimagnetic shape of M(H) curves and saturated magne-
tization values of dry SPIONs and SPIONs-PAA (amountingM0 ¼ 69
emu/g and M0 ¼ 62 emu/g, respectively) were typical for g-Fe2O3-
composed nanoparticles (Fig. 1d). The zero-ﬁeld-cooled (zfc) and
ﬁeld-cooled (fc) magnetic susceptibilities, c ¼ M/H, of dry SPIONs
and SPIONs-PAA, measured in a magnetic ﬁeld H ¼ 100 Oe, showed
czfc - cfc splitting at about 280 K, whereas a broad maximum in czfc
was observed at the temperature TB ¼ 185 K. This could be asso-
ciated with the superparamagnetic blocking temperature below
which SPIONs’ spin reorientation is frozen on the experimental
time scale. The TB ¼ 185 K value was consistent with TEM-
estimated diameters of SPIONs and SPIONs-PAA, as for larger
SPIONs TB shifts above the room temperature. Similarly, czfc - cfc
splitting and TB z 300 K were observed for SPIONs-PAA, where
slightly higher values, as compared to SPIONs, very likely originated
from their slightly larger size. Magnetic characterization of dry
SPIONs and SPIONs-PAA thus conﬁrmed their superparamagnetic
nature and small size with diameters in the range 8e10 nm. The
M(H) curves and the magnetic susceptibility c ¼ M/H of ferroﬂuids
(FFs), denoting water-based suspension of SPIONs (FF-SPIONs) and
SPIONs-PAA (FF-SPIONs-PAA), were also determined. The M(H)
shapes remained those of the dry samples (the diamagnetic
susceptibility of water is negligible as compared to the ferrimag-
netic susceptibility of g-Fe2O3-composed SPIONs). The difference in
magnetization values between FF-SPIONs and FF-SPIONs-PAA
originated from different concentration of nanoparticles in the
suspensions (FF-SPIONs > FF-SPIONs-PAA). The temperature-
dependent zfc and fc susceptibilities of FFs displayed discontinu-
ities in the vicinity of T ¼ 0 C ¼ 273 K (marked by vertical dashed
line), which was a consequence of FFs freezing upon cooling and
melting upon heating. By measuring the fc susceptibility in a cool-
ing run, starting at 300 K, FFs freezed at 260 K. In the zfc suscep-
tibility measurements performed in a heating run, starting at 2 K,
melting of FFs started at 273 K.
Zeta potentials of FF-SPIONs at pH 9.5 and FF-SPIONs-PAA at pH
8.5 were z ¼ 24  2 mV and z ¼ 47  2 mV, respectively, indi-
cating negative surface charge of SPIONs as well as SPIONs-PAA and
good stability of FF-SPIONs-PAA due to strong mutual electrostatic
repulsion. Zeta potential of the FF-SPIONs-PAA-PEI at pH 8 was
z ¼ 20  1 mV, indicating positive surface charge of SPIONs-PAA-
PEI due to the functionalization of SPIONs-PAA’s surface with PEI.
3.2. In vitro
3.2.1. Cytotoxicity of SPIONs-PAA-PEI and SPIONs-PAA-PEI-pDNAGFP
on cells of different cell lines
We tested cytotoxicity of SPIONs-PAA-PEI and SPIONs-PAA-PEI
bound to pDNAGFP (SPIONs-PAA-PEI-pDNAGFP) on mouse mela-
noma B16F1 cells, human melanoma SK-MEL-28 cells, mouse
ﬁbroblasts L929 and human mesothelial MeT-5A cells, and
Fig. 1. Physicochemical properties of SPIONs, SPIONs-PAA, SPIONs-PAA-PEI and SPIONs-PAA-PEI-pDNAGFP: (a) Transmission electron micrographs of spherical SPIONs, SPIONs-PAA,
SPIONs-PAA-PEI and SPIONs-PAA-PEI-pDNAGFP. 12 nm-sized SPION-PAA-PEI has an amorphous 1e2 nm edge (double arrows). SPIONs-PAA-PEI are entrapped inside organic bubble-
like-formation (pDNA) forming SPIONs-PAA-PEI-pDNAGFP (arrows). (b) X-ray diffractograms of SPIONs and SPIONs-PAA exhibit characteristic peaks for iron oxide maghemite (g-
Fe2O3). (c) Retardation of pDNAIL12 and pDNAGFP bound to SPIONs-PAA-PEI (lanes 1 and 5, respectively), and to PEI (lanes 2 and 6, respectively) (arrows). Separation of pDNAIL12
and pDNAGFP (lanes 3 and 7, respectively) as well as pDNAIL12 and pDNAGFP that did not bound to SPIONs-PAA (lanes 4 and 8, respectively). Molecular weight markers (M). (d)M(H)
curves, the saturated magnetization and temperature dependent zero-ﬁeld-cooled (zfc) and ﬁeld-cooled (fc) magnetic susceptibilities, c ¼ M/H, of dry SPIONs and SPIONs-PAA and
ferroﬂuids containing SPIONs (FF-SPIONs) and SPIONs-PAA (FF-SPIONs-PAA). All data are for a representative sample.
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toxicity of an external magnetic ﬁeld generated by Nd-Fe-B
magnets on cells of all four cell lines in comparison to cells not
exposed to an external magnetic ﬁeld was observed (Fig. 2a).
Therefore, results regarding cytotoxicity of a certain substance as
well as comparisons between the substances will be interpreted
referring to the presence of an external magnetic ﬁeld. No
substance decreased cell survival below 50% in all cell lines. In
general, cells of all cell lines exhibited similar toxicity-related
patterns to added substances. Only for MeT-5A cells, survival was
signiﬁcantly decreased after exposure to pDNAGFP (60%) in
comparison to SPIONs-PAA, PEI and SPIONs-PAA-PEI. Pronouncedsensibility of MeT-5A cells to pDNAGFP might be due to their
spontaneous transfection which we observed during the experi-
ments (data not shown). Survivals of cells of all cell lines, treated
with SPIONs-PAA-PEI, alternated between 82% and 86%. Binding of
pDNAGFP to SPIONs-PAA-PEI (SPIONs-PAA-PEI-pDNAGFP) signiﬁ-
cantly decreased cell survival, probably due to the compromised
cell membrane integrity after internalization of SPIONs-PAA-PEI-
pDNAGFP, which was followed by magnetofection (See further
results). Similar was observed after treatments of cells with PEI-
pDNAGFP. SPIONs-PAA-PEI-pDNAGFP displayed tendency of being
less cytotoxic than PEI-pDNAGFP in all cell lines, however, only in
L929 cells signiﬁcant difference in cell survival after the exposure to
Fig. 2. Cytotoxicity and internalization of SPIONs-PAA-PEI-pDNAGFP: (a) Cytotoxicity of SPIONs-PAA-PEI and SPIONs-PAA-PEI-pDNAGFP on B16F1, SK-MEL-28, L929 and MeT-5A cells
in comparison to PEI-pDNAGFP in the absence and presence of an external magnetic ﬁeld. *P < 0.05, **P < 0.01, between the compared groups (n ¼ 12). (b,c) Internalization of
SPIONs-PAA-PEI-pDNAGFP into cells of different cell lines after 4-h incubation with SPIONs-PAA-PEI-pDNAGFP. (b) Quantitative determination of internalized SPIONs-PAA-PEI-
pDNAGFP corresponds to the Fe concentration per cell. (c) Transmission electron micrographs of B16F1, SK-MEL-28, L929 and MeT-5A cells with internalized SPIONs-PAA-PEI-
pDNAGFP complexes after 15-min exposure to an external magnetic ﬁeld. SPIONs-PAA-PEI-pDNAGFP inside endocytotic compartments with intact membranes (arrowheads).
Pseudopodia-like formations (arrows) coinciding with the invagination of the cell membrane. Scale bar, 500 nm ﬁrst and third column; 200 nm second and fourth column. (d)
Internalization of SPIONs-PAA-PEI-pDNAGFP into B16F1 cells after 24-h incubation with SPIONs-PAA-PEI-pDNAGFP subsequent to 15-min exposure to an external magnetic ﬁeld.
Transmission electron micrographs (clockwise): The internalized SPIONs-PAA-PEI-pDNAGFP inside the endocytotic compartment (arrow) beneath the cell surface. SPIONs-PAA-PEI-
pDNAGFP in the endocytotic compartment with intact membrane, and organic compound separation (arrow). SPIONs-PAA-PEI-pDNAGFP in the endocytotic compartment with
disrupted membrane (arrow). Vacuoles without SPIONs-PAA-PEI-pDNAGFP (arrowheads). Scale bar, 200 nm. (e) Schematic showing the process of internalization of SPIONs-PAA-
PEI-pDNAGFP followed by subsequent magnetofection of the cell after exposure to an external magnetic ﬁeld in a 24 h time scale.
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to the latest was observed.
3.2.2. Internalization of SPIONs-PAA-PEI-pDNAGFP into cells
Internalization of SPIONs-PAA-PEI bound to pDNAGFP (SPIONs-
PAA-PEI-pDNAGFP) was evaluated quantitatively and qualitatively.
Quantitative analysis demonstrated internalization of SPIONs-PAA-
PEI-pDNAGFP into cells of all cell lines at 4 h after the incubation
with SPIONs-PAA-PEI-pDNAGFP and exposure to an external
magnetic ﬁeld for different time intervals (Fig. 2b). Internalization
of SPIONs-PAA-PEI-pDNAGFP corresponds to the cellular iron (Fe)
concentration. No statistically signiﬁcant differences in Fe
concentration between the cell lines were noticed. In all cell lines
directly proportional tendency between the time interval exposure
to an external magnetic ﬁeld and Fe concentration was found.
However, no statistically signiﬁcant differences in Fe concentration
between 0 and 30min exposures to an externalmagnetic ﬁeld were
determined. Additionally, in B16F1 and L929 cells plateau level at
15-min exposure to an external magnetic ﬁeld was observed.
According to these results, intermediate time interval exposure
(15 min) to an external magnetic ﬁeld was chosen for the imple-
mentation into further experiments for magnetofection of cells
with pDNAGFP or pDNAIL12.
In agreement with the results of quantitative analysis, at 4 h
after incubation with SPIONs-PAA-PEI-pDNAGFP that included 15-
min exposure of cells to an external magnetic ﬁeld, internaliza-
tion of complexes was observed in cells of all cell lines (Fig. 2c). Due
to the size of the complexes (approx. 200e400 nm), the cellular
uptake was determined to be phagocytosis. Moreover, distinctive
pseudopodia-like formations were observed in cells of all cell lines.
The complexes were observed in the endocytotic compartments
with intact membranes. No SPIONs-PAA-PEI-pDNAGFP complexes
outside the endocytotic compartments neither in the cytoplasm
nor in the nucleus were observed. At 24 h after incubation with
SPIONs-PAA-PEI-pDNAGFP, the complexes were observed in the
endocytotic compartments of B16F1 cells with intact as well as
disrupted membranes (Fig. 2d). No SPIONs-PAA-PEI-pDNAGFP were
observed in the cytoplasm, however, separation of organic
compound (pDNAGFP) from the complexes within the endocytotic
compartments and vacuoles without SPIONs-PAA-PEI-pDNAGFP
were detected. Schematic showing the processes of internalization
of SPIONs-PAA-PEI-pDNAGFP followed by subsequent magneto-
fection after exposure of a cell to an external magnetic ﬁeld in
a 24 h time scale (Fig. 2e).
3.2.3. Magnetofection of cells with pDNAGFP using SPIONs-PAA-PEI
Magnetofection with pDNAGFP using SPIONs-PAA-PEI was per-
formed in four cell lines: B16F1, SK-MEL-28, L929 and MeT-5A, and
compared to the transfection using PEI only (Fig. 3a). Optimization
of magnetofection was conducted by preparing SPIONs-PAA, PEI
and pDNAGFP at different mass ratios. Among the cell lines B16F1
cells exhibited the highest percentage of ﬂuorescent cells (47%) at
the mass ratio of 0.6:1:1, however, MeT-5A cells displayed the
highest ﬂuorescence intensity (11,943 a.u.) at the mass ratio 0.5:1:1.
The lowest percentage of ﬂuorescent cells (2%) as well as the lowest
ﬂuorescence intensity (520 a.u.) was observed in L929 cells. The
percentage of ﬂuorescent SK-MEL-28 cells (13%) was similar to that
of MeT-5A cells (12%), however, their ﬂuorescence intensity (4,169
a.u.) was only higher than that of L929. In all cell lines, exposure of
cells to an external magnetic ﬁeld contributed to the increase in the
percentage of ﬂuorescent cells only at the mass ratio 0.9:1:1,
however the highest percentage of ﬂuorescent B16F1 cells was
observed at the mass ratio 0.6:1:1. Interestingly, an external
magnetic ﬁeld did not contribute to the increase in the percentage
of ﬂuorescent B16F1 cells only at that mass ratio. In comparison tothe transfection with pDNAGFP using PEI prepared as PEI-pDNAGFP
at the mass ratio 1:1, signiﬁcant increase in the percentage of
ﬂuorescent B16F1 cells at the mass ratio 0.6:1:1 was observed.
According to all these results, mass ratio 0.6:1:1 was chosen to be
implemented in further experiments on B16F1 cells (Fig. 3b).
Photomicrographs taken under ﬂuorescence epi-illumination
support the quantitative results with the GFP expression
observed in all cell lines in the absence and presence of an external
magnetic ﬁeld (Fig. 3c). The GFP levels observed from the photo-
micrographs indicated differences in transfection efﬁcacy at the
level of the cell line as well as some alterations in the absence and
presence of an external magnetic ﬁeld were noticed. In agreement
with the results obtained from quantitative analysis, B16F1 cells
showed the highest GFP level whereas L929 cells resulted in the
lowest.
Magnetofection of B16F1 cells with pDNAGFP using SPIONs-PAA-
PEI was compared to transfection using PEI, 3 commercially avail-
able magnetic nanoparticles, electroporation, lipofection and
SPIONs-PAA-PEI in the absence of an external magnetic ﬁeld
(Fig. 3d). Magnetofection using SPIONs-PAA-PEI resulted in excel-
lent transfection efﬁcacy, which was comparable to electro-
poration, lipofection and SPIONs-PAA-PEI in the absence of an
external magnetic ﬁeld. However, SPIONs-PAA-PEI outperformed
PEI and all commercially available magnetic nanoparticles for
magnetofection either in the percentage of ﬂuorescent cells or in
the ﬂuorescence intensity.
3.2.4. Magnetofection of cells with pDNAIL12 using SPIONs-PAA-PEI
Magnetofection of B16F1 cells with pDNAIL12 using SPIONs-
PAA-PEI was compared to transfection using PEI, electroporation,
lipofection and SPIONs-PAA-PEI in the absence of an external
magnetic ﬁeld (Fig. 3e). The secretion of IL-12 from B16F1 cells into
medium was observed after transfection with all the methods
tested. Magnetofection resulted in 12.6-fold and 7.2-fold increase in
transfection efﬁciency in comparison to PEI and lipofection,
respectively. No statistically signiﬁcant differences in transfection
efﬁcacy using SPIONs-PAA-PEI in the absence and presence of
magnetic were observed, however, IL-12 secretion was increased
for 1.2-fold in the presence over the absence of an external
magnetic ﬁeld.
3.3. In vivo
3.3.1. Acute toxicity and biodistribution of SPIONs-PAA and SPIONs-
PAA-PEI
The acute toxicity was determined according to the OECD
guidelines. The i.p. administration of the highest dose injected,
550 mg/kg of SPIONs-PAA, did not result in any death in the time
period of 14 days after injection. Therefore, LD50 determinationwas
not possible. The highest dose suggested to be used by OECD
guidelines (2000 mg/kg) was not possible to inject due to the
restricted i.p. injection volume and limited highest concentration of
SPIONs-PAA in stock solution. A slight but non-signiﬁcant decrease
in body weight was observed on day 4 after the ﬁrst administration
of SPIONs-PAA as well as distilled water, but after day 4 the body
weight started to rise (Fig. 4a).
After the i.p. administration of 175 mg/kg and 550 mg/kg of
SPIONs-PAA, Fe concentrations were elevated in spleen and liver
(Fig. 4b). In spleen, Fe concentrations were increased for 1.9-fold
and 2.5-fold after administration of 175 mg/kg and 550 mg/kg of
SPIONs-PAA, respectively, in comparison to the Fe concentration
measured in the spleen of control mice. Similarly in liver, Fe
concentrations were increased after administration of 175 mg/kg
and 550 mg/kg of SPIONs-PAA for 1.5-fold and 3.4-fold, respec-
tively, in comparison to the Fe concentration measured in the liver
Fig. 3. Magnetofection of cells using SPIONs-PAA-PEI: (a) Determination of the GFP level, measured as the percentage of ﬂuorescent (FL) cells and median ﬂuorescence (FL)
intensity, in B16F1, SK-MEL-28, L929 and MeT-5A cells after transfection with pDNAGFP using SPIONs-PAA-PEI prepared as SPIONs-PAA-PEI-pDNAGFP at mass ratios from 0.5:1:1 to
0.9:1:1 in the absence and presence of magnetic ﬁeld. Mass ratio 1:1 denotes PEI-pDNAGFP. *P < 0.01, **P < 0.001, comparison between mass ratios. yP < 0.05, yyP < 0.01, yyyP < 0.001,
compared to the absence of an external magnetic ﬁeld (n ¼ 4 or 11). (b) The GFP level and increase after magnetofection of cells using SPIONs-PAA-PEI prepared as SPIONs-PAA-PEI-
pDNAGFP at the mass ratio 0.6:1:1. (c) Micrographs of B16F1, SK-MEL-28, L929 and MeT-5A cells after transfection with pDNAGFP using SPIONs-PAA-PEI prepared as SPIONs-PAA-PEI-
pDNAGFP at the mass ratio 0.6:1:1 in the absence and presence of magnetic ﬁeld under phase contrast (PC) and ﬂuorescence epi-illumination (FL) (60 magniﬁcation). (d,e)
Magnetofection of B16F1 cells with pDNAGFP or pDNAIL12 using SPIONs-PAA-PEI, prepared as SPIONs-PAA-PEI-pDNAGFP or SPIONs-PAA-PEI-pDNAIL12 at the mass ratio 0.6:1:1, in
comparison to other methods. (d) The GFP level in B16F1 cells. *P < 0.01, compared to SPIONs-PAA-PEI magnet (FL cells). yP < 0.05, yyP < 0.01, compared to SPIONs-PAA-PEI magnet
(FL intensity) (n ¼ 7e13). (e) The secretion of IL-12 from B16F1 cells.*P < 0.01, compared to SPIONs-PAA-PEI magnet (n ¼ 3).
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Fig. 4. Change in body weight after the i.p. administration of high doses of SPIONs-PAA and biodistribution of SPIONs-PAA and SPIONs-PAA-PEI-pDNAGFP after i.p. administration of
low and high doses: (a) Change in body weight. Symbols represent the ratios of intermediate and ﬁnal body weights to initial body weight. The experiment was performed in one
mouse per dosage due to the OECD guidelines. (b) Biodistribution of high doses of SPIONs-PAA. The experiment was performed in one mouse per dosage due to the OECD guidelines.
Bars represent absolute values. (c) Biodistribution of low doses of SPIONs-PAA and SPIONs-PAA-PEI-pDNAGFP. (d) Micrographs of mice liver stained with Perl’s Prussian blue after
administration of distilled water (control) and two different high doses of SPIONs-PAA.
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regarding pDNAIL12 dosage optimization after i.t. administration
followed by electroporation of tumors [27], mice were also injected
i.p. with low doses of SPIONs-PAA (1.2 mg/kg) and SPIONs-PAA-PEI-
pDNAGFP (1.2-2-2 mg/kg) to evaluate the biodistribution. No
signiﬁcant differences in Fe concentration within the organs
between the control group and low doses-treated groups of mice
with SPIONs-PAA and SPIONs-PAA-PEI-pDNAGFP were detected
(Fig. 4c).
In agreement with the results of quantitative analysis, Perl’s
Prussian blue staining of the control liver indicated SPIONs-PAA
free organ whereas after the administration of high doses of
SPIONs-PAA blue precipitates with Fe3þ, indicating the accumula-
tion of SPIONs-PAA, in the phagocytes of the reticulo-endothelial
system were detected (Fig. 4d).
3.3.2. Magnetofection of tumors with pDNAGFP using SPIONs-PAA-
PEI
Magnetofection of tumors with pDNAGFP using SPIONs-PAA-PEI
was tested in two tumor models: B16F1 melanoma syngeneic to
C57Bl/6 mice due to the highest magnetofection efﬁcacy of B16F1
cells in vitro, and TS/A mammary adenocarcinoma syngeneic to
BALB/c mice, in which acute toxicity and biodistribution were
determined. Also, we were interested in howweakly immunogenic
TS/A mammary adenocarcinoma [29] would respond to immuno-
gene therapy with pDNAIL12.
As demonstrated from the frozen tumor sections, magneto-
fection of B16F1 melanoma and TS/A mammary adenocarcinoma
tumors with pDNAGFP using SPIONs-PAA-PEI was effective (Fig. 5a).
The GFP level in B16F1 tumors was observed either after 30-minexposure to an external magnetic ﬁeld or in the absence of an
external magnetic ﬁeld. However, without an external magnetic
ﬁeld exposure, the GFP level in TS/A tumors after transfection with
SPIONs-PAA-PEI was barely visible. Importantly, no transfection of
both tumors with pDNAGFP using PEI was observed (data not
shown). Hence, by combining PEI with SPIONs-PAA, increased
transfection efﬁciency in vitrowas achieved and magnetofection of
two different murine tumors was proved in vivo. Gene electro-
transfer of tumors was used as a positive control since it is known
and well established non-viral transfection method of tumors
[30,31]. Gene electrotransfer resulted in homogenous GFP spatial
distribution whereas after magnetofection scattered GFP spatial
distribution was observed (Fig. 5a). The effect of an external
magnetic ﬁeld on magnetofection of melanoma B16F1 and
mammary adenocarcinoma TS/A tumors with pDNAGFP using
SPIONs-PAA-PEI was more pronounced in TS/A than in B16F1
tumors.
3.3.3. Magnetofection of tumors with pDNAIL12 using SPIONs-PAA-
PEI
Magnetofection of TS/A mammary adenocarcinoma tumors
with pDNAIL12 using SPIONs-PAA-PEI resulted as effective treat-
ment in BALB/c mice (Fig. 5b). Three consecutive treatments lead to
statistically signiﬁcant reduction in the tumor volume compared to
non-treated tumors. The effect of the treatment was noticed 2 days
after the completion of the treatment. The signiﬁcant antitumor
effect was seen only when the tumors were exposed to an external
magnetic ﬁeld whereas in the absence there was no antitumor
effect. Gene electrotransfer of pDNAIL12 has in other studies
already resulted in tumor growth regression [27,32]. Thus, we used
Fig. 5. Magnetofection of tumors with pDNAGFP or pDNAIL12 using SPIONs-PAA-PEI: (a) Micrographs of frozen murine melanoma B16F1 and mammary adenocarcinoma TS/A
tumor sections under phase contrast (PC) and epi-ﬂuorescence illumination (FL) after transfection with pDNAGFP using (A) magnetofection, (B) SPIONs-PAA-PEI in the absence of
magnetic ﬁeld, (C) electrotransfer. Scale bar, 50 mm. (b) Antitumor effect of i.t. administration of pDNAIL12 on TS/A mammary adenocarcinoma tumors after magnetofection with
SPIONs-PAA-PEI and electrotransfer. Blue arrows represent three consecutive treatments with pDNAIL12. Tumor growth delay was calculated on the 10th day. (c) The effect of
cancer immuno-gene therapy with pDNAIL12 on TS/A mammary adenocarcinoma tumors. *P < 0.05, **P < 0.01, compared to control (n ¼ 5).
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tofection it resulted in statistically signiﬁcant antitumor effect in
comparison to untreated control tumors (Fig. 5c). Tumor growth
delay was calculated at the tumor volume 200 mm3 because
tumors of SPIONs-PAA-PEI-pDNAIL12-treated mice and after
pDNAIL12 electrotransfer started to delay in growth after they had
already reached doubling or tripling volume (Fig. 5b). The effect of
magnetofection and gene electrotransfer was comparable: gene
therapy of tumors with pDNAIL12 resulted in 7.8 1.3 and 6.6 1.1
days tumor growth delays, respectively. In all the other control
groups no antitumor effect was observed (Fig. 5c).
4. Discussion
Biocompatibility and biodistribution of every nanoparticulate
delivery system should be determined since the physicochemical
properties, such as size, shape and surface characteristics, might
govern their brand new behavior and safety in vitro and in vivo [33].
In vitro, survival of cells of all cell lines was after treatment with
SPIONs-PAA-PEI subsequent to 15-min exposure to an external
magnetic ﬁeld still around 80%, which is similar to the cytotoxicity
of silica-coated SPIONs [34]. PEI-related cytotoxicity of PEI-
pDNAGFP reduced cell survival up to 50%, and was statistically
signiﬁcantly diminished by associating PEI-pDNAGFP to SPIONs-PAA
only in ﬁbroblasts L929. In general, SPIONs-PAA-PEI-pDNAGFP
decreased survival of cells to approximately 70%, which indicated
that they were not vastly cytotoxic, and could be further used in
animal studies. In vivo, i.p. administration of 175 mg/kg and
550 mg/kg of SPIONs-PAA did not reach the LD50. To date, there are
no other reports about the in vivo toxicity of g-Fe2O3-composed,
PAA-coated and PEI-functionalized SPIONs. Different research
groups selected different coatings, functionalization and cargos for
SPIONs as delivery systems, thus the comparison between the
studies evaluating LD50 of so diversiﬁed SPIONs is virtually
impossible. Nonetheless, acute toxicity-based study in mice
showed that LD50 for magnetite (Fe3O4)-composed and dextran-
coated magnetic nanoparticles after i.p. administration is above
2000 mg/kg [35]. Other studies in mice revealed that after i.p.
administration LD50 for Fe3O4-composed and daunorubicin-loaded
magnetic nanoparticles is 1010 mg/kg [36], and for Fe3O4-
composed and Au-coated magnetic nanoparticles LD50 is 8390 mg/
kg [37]. In our study, the i.p. administration of high doses of
SPIONs-PAA resulted in their accumulation inside the phagocytes of
the reticulo-endothelial system of spleen and liver. Histologically,
no damages in the liver of low and high dose SPIONs-PAA-treated
mice were detected because iron-induced hepatocellular injury
does not occur when SPIONs are taken up by reticuloendothelial
cells [38]. The i.p. administration of low doses of SPIONs-PAA as
well as SPIONS-PAA-PEI-pDNAGFP did not result in any alterations in
the histological specimen (data not shown) as well as in the level of
iron measured in the internal organs of mice. On the other hand,
Trubetskoy et al. observed extensive parenchymal destruction of
the mice liver after i.v. administration of complexes composed of
PAA, PEI and pDNA, but without SPIONs, at slightly higher dose
than ours [23]. This suggests that in vivo usage of our SPIONs-PAA-
PEI-pDNAGFP is safe when their mass ratio and dosage is carefully
constructed.
Cellular uptake of SPIONs for magnetofection is the doorway for
efﬁcient nucleic acid delivery to the cell nucleus. It has been shown
in many studies that malignant cells internalize more SPIONs than
normal cells [34,39,40]. After 4-h incubation, we detected inter-
nalized SPIONs-PAA-PEI-pDNAGFP at the mass ratio 0.6:1:1 in cells
of all four cell lines, however, at that time no statistically signiﬁcant
differences in the internalization between normal and malignant
cells were measured. On the other hand, after 24-h incubation,diverse GFP levels among the cell lines were determined: malig-
nant mouse B16F1 and human SK-MEL-28 melanoma cells out-
performed normal human mesothelial MeT-5A cells and mouse
ﬁbroblasts L929. After 24-h incubation, no SPIONs-PAA-PEI-
pDNAGFP inside the nuclei of B16F1 cells were detected, but we
observed internalized SPIONs-PAA-PEI-pDNAGFP in the endocytotic
compartments with disrupted membranes, which indicates the
infamous PEI-related proton sponge effect mechanism [41]. The
direct evidence that PAA as an endosomolytic polymeric anion also
contributed to the membrane disruption could not be observed,
however, increased levels of GFP and IL-12 obtained after magne-
tofection of B16F1 cells with SPIONs-PAA-PEI in comparison to PEI
is an indirect indication.
To further evaluate SPIONs-PAA-PEI as delivery systems for
pDNA in vitro and in vivo, we ﬁrst compared in vitro efﬁcacy of
magnetofection of mouse melanoma B16F1 cells with pDNAGFP and
pDNAIL12 using SPIONs-PAA-PEI to the efﬁcacy of transfection
using PEI, 3 commercially available magnetic nanoparticles for
magnetofection, electroporation, lipofection and SPIONs-PAA-PEI
in the absence of an external magnetic ﬁeld. PEI is well known
transfection agent with pronounced endosomolytic properties [19],
however, when coupled with SPIONs, synergistic effect in trans-
fection efﬁcacy has been observed [11,20,21]. Coating and func-
tionalization of SPIONs with PAA and PEI, respectively, signiﬁcantly
increased magnetofection efﬁcacy of mouse melanoma B16F1 cells
with pDNAGFP and pDNAIL12 in comparison to the transfection
using PEI only. Moreover, SPIONs-PAA-PEI outperformed all
commercially available magnetic nanoparticles that we tested
either at the percentage of GFP-positive cells or at the ﬂuorescence
intensity of GFP. Magnetofection efﬁcacy of B16F1 cells with
pDNAGFP using SPIONs-PAA-PEI was about the same as that
obtained by lipofection and electroporation. In another study
transfection of B16F1 cells with pDNAGFP using electroporation
resulted in approx. 1.5-fold more GFP-positive cells that we
observed after electroporation [42]. However, for more accurate
evaluation of transfection efﬁcacy also the ﬂuorescence intensity of
GFP, indicating the amount of the protein synthesized, should be
taken into account. The amount of secreted IL-12 from B16F1 cells
was statistically signiﬁcantly higher aftermagnetofection than after
transfection with PEI and lipofection. Cationic lipids efﬁciently
deliver pDNA by endocytosis [43], and destabilize ﬂuid lipid bila-
yers of cell membranes by promoting the formation of non-bilayer
lipid structures [44]. Signiﬁcantly lower amount of secreted IL-12
from B16F1 cells after lipofection in comparison to magneto-
fection and electroporation might indicate liposome-induced
alterations in cell membrane resulting in diminished exocytosis-
mediated protein secretion.
Magnetofection of tumors with pDNAGFP using SPIONs-PAA-PEI
was the ﬁrst step in evaluating the efﬁcacy of our gene delivery
system also in vivo. To date, only two research groups report about
efﬁcient non-virally-associated magnetofection of tumors with
pDNA encoding reporter gene with PEI-PEG-chitosan copolymer-
coated magnetic nanoparticles or magnetic crystal-lipid nano-
structure [45e47]. In our study, the effect of an external magnetic
ﬁeld on magnetofection of melanoma B16F1 and mammary
adenocarcinoma TS/A tumors with pDNAGFP using SPIONs-PAA-PEI
was more pronounced in TS/A tumors than in B16F1 tumors. In the
second step we evaluated the antitumor effectiveness of pDNAIL12
after magnetofection with our SPIONs-PAA-PEI in weakly immu-
nogenic TS/A mammary adenocarcinoma [29]. The therapeutic
effect after magnetofection of TS/A tumors with pDNAIL12 using
SPIONs-PAA-PEI was signiﬁcantly better than administration of
SPIONs-PAA-PEI-pDNAIL12 in the absence of an external magnetic
ﬁeld. In fact, there was no antitumor effect without the exposure of
tumors to an external magnetic ﬁeld. Interestingly, the contribution
S. Prijic et al. / Biomaterials 33 (2012) 4379e43914390of an external magnetic to the magnetofection efﬁcacy was not
seen in vitro but only in vivo. In vitro, internalization of SPIONS is
usually limited by the lack of contact between SPIONs and cellular
surface, and can be enhanced by increasing either gravitational or
magnetic force. The gravitational force is a function of particle
density and radius, and in standard in vitro conditions causes the
sedimentation of SPIONs onto the cellular surface [48]. The gravi-
tational force might have enabled 250 nm-sized SPIONs-PAA-PEI-
pDNAGFP and SPIONs-PAA-PEI-pDNAIL12 to sediment onto the
cellular surface during 4-h incubation, thus the exposure of cells to
an external magnetic ﬁeld could not additionally contribute to the
sedimentation onto the cellular surface, subsequent internalization
and nevertheless magnetofection of cells. In vivo, i.t. administration
of SPIONs-PAA-PEI-pDNAIL12 with subsequent exposure to an
external magnetic ﬁeld resulted in signiﬁcant antitumor effect. The
exposure of tumors to an external magnetic ﬁeld after adminis-
tration of SPIONs prolonged their retention at the targeted site
[8,11,49], which might have contributed to the increased magne-
tofection efﬁcacy of the magnet-exposed tumors. However, further
studies are needed in order to elucidate the importance of an
external magnetic ﬁeld for the treatment of different tumors using
magnetofection.
To the best of our knowledge, pDNA encoding therapeutic genes
was delivered into tumors by magnetofection in only two studies
by the same research group, dealing with dose-escalation neo-
adjuvant gene therapy of feline ﬁbrosarcomas before surgery
[14,16]. Magnetofection of ﬁbrosarcomas turned out to be safe and
efﬁcient with the use of intermediate pDNA dose, which was
explained by the bell-shaped dose dependence of IL-2 [50]. In our
study, magnetofection of TS/A tumors with pDNAIL12 resulted in
signiﬁcant antitumor effect as the only treatment modality.
Furthermore, the effect of IL-12-based treatments of TS/A tumors
after magnetofection was equal to the one of well-established and
efﬁcacious non-viral gene delivery methods in vivo e gene elec-
trotransfer [27,51]. Three repetitive treatments with the same
dosage of pDNAIL12 resulted in the same signiﬁcant antitumor
effect. Magnetofection of tumors with pDNAIL12 using SPIONs-
PAA-PEI can be further reﬁned for cancer immuno-gene therapy,
which can be very efﬁcient in combination with other treatment
modalities, e.g. irradiation [52], particularly for the patients whose
tumors cannot be removed by surgery [53].
5. Conclusion
The combination of coating and functionalization of SPIONs
using PAA and PEI pH-responsive endosomolytic polymers as
membrane disruptive agents proved to be nontoxic and effective
for in vitro magnetofection of different cells with pDNA encoding
either GFP or IL-12, and even superior in transfection efﬁcacy than
some other non-viral transfection approaches. In vivo, we demon-
strated that magnetofection of mammary adenocarcinoma TS/A
tumors with pDNA encoding IL-12 using SPIONs-PAA-PEI resulted
in signiﬁcant antitumor effect and could be further developed for
cytokine-based tumor gene therapy.
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